Innovation in urothelial cancer 2025
Auditorio Reina Sofía C/ de Oña,10, 28050 Madrid
Jueves 11 diciembre 2025 16:00h – 17:30h
Presentation of event
Event coordinators
Event schedule
-
Welcome and Introduction
16:00 h – 16:10 h
-
SESSION I – EARLY-STAGE DISEASE
16:10 h – 16:30 h
NMIBC in Transformation: Is it Time to Integrate Immunotherapy?
- Redefining BCG unresponsiveness
- Practical considerations of long-term subcutaneous immunotherapy
- How should we define BCG failure in 2025?
- What is the role of the multidisciplinary team?
-
SESSION II – MIBC & BLADDER-SPARING STRATEGIES
16:30 h – 17:30 h
- Muscle-Invasive Disease: Response- and ctDNA-Guided Personalization
- Insights from neoadjuvant trials: can we avoid cystectomy
- ctDNA vs pCR as prognostic tools
- Defining cCR and optimizing bladder preservation
- Can ctDNA clearance guide treatment de-escalation?
-
CLOSING DISCUSSION
18:15 h – 18:30 h
- Open Q&A and Final Remarks
- What should change in our clinical practice after tomorrow?
- What research questions remain unanswered?
Suscríbete y cuida tu salud
Recibe contenido exclusivo sobre prevención de la salud y tratamientos. La mejor forma de cuidar tu bienestar comienza con estar informado.